Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hirokuni Taguchi

Showing results (71-80 of 74) with videos related to

Pageof 8
Sort By:
You have reached the last page of results.This site can display upto 74 results.
Blood|July 7, 2005
Humanized anti-interleukin-6 receptor antibody treatment of multicentric Castleman diseaseNorihiro Nishimoto, Yuzuru Kanakura, Katsuyuki Aozasa, et al.
Molecular and Cellular Biology|July 1, 2005
A human T-cell lymphotropic virus type 1 enhancer of Myc transforming potential stabilizes Myc-TIP60 transcriptional interactionsSoumya Awasthi, Anima Sharma, Kasuen Wong, et al.
International Journal of Hematology|November 16, 2004
Efficacy and safety of imatinib mesylate for patients in the first chronic phase of chronic myeloid leukemia: results of a Japanese phase II clinical studyYasuo Morishima, Michinori Ogura, Miki Nishimura, et al.
Molecular Cancer Therapeutics|December 17, 2002
Prediction of chemosensitivity for patients with acute myeloid leukemia, according to expression levels of 28 genes selected by genome-wide complementary DNA microarray analysisJun-ichi Okutsu, Tatsuhiko Tsunoda, Yasuyuki Kaneta, et al.
Pageof 8

Showing results (71-80 of 74) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 74 results.
Blood|July 7, 2005
Humanized anti-interleukin-6 receptor antibody treatment of multicentric Castleman diseaseNorihiro Nishimoto, Yuzuru Kanakura, Katsuyuki Aozasa, et al.
Molecular and Cellular Biology|July 1, 2005
A human T-cell lymphotropic virus type 1 enhancer of Myc transforming potential stabilizes Myc-TIP60 transcriptional interactionsSoumya Awasthi, Anima Sharma, Kasuen Wong, et al.
International Journal of Hematology|November 16, 2004
Efficacy and safety of imatinib mesylate for patients in the first chronic phase of chronic myeloid leukemia: results of a Japanese phase II clinical studyYasuo Morishima, Michinori Ogura, Miki Nishimura, et al.
Molecular Cancer Therapeutics|December 17, 2002
Prediction of chemosensitivity for patients with acute myeloid leukemia, according to expression levels of 28 genes selected by genome-wide complementary DNA microarray analysisJun-ichi Okutsu, Tatsuhiko Tsunoda, Yasuyuki Kaneta, et al.
Pageof 8